+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019

  • ID: 4898197
  • Report
  • December 2019
  • Region: Global
  • 128 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CroiValve Ltd
  • Daidalos Solutions BV
  • LivaNova PLC
  • Revivicor Inc
  • Tissue Regenix Ltd
  • MORE
Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019

Summary

The Medical Devices sector report, “Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019“ provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Vascular Inc
  • CroiValve Ltd
  • Daidalos Solutions BV
  • LivaNova PLC
  • Revivicor Inc
  • Tissue Regenix Ltd
  • MORE
1 Introduction
1.1 Tissue Heart Valves Overview

2 Products under Development
2.1 Tissue Heart Valves - Pipeline Products by Stage of Development
2.2 Tissue Heart Valves - Pipeline Products by Segment
2.3 Tissue Heart Valves - Pipeline Products by Territory
2.4 Tissue Heart Valves - Pipeline Products by Regulatory Path
2.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date
2.6 Tissue Heart Valves - Ongoing Clinical Trials

3 Tissue Heart Valves - Pipeline Products under Development by Companies
3.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development
3.2 Tissue Heart Valves - Pipeline Products by Stage of Development

4 Tissue Heart Valves Companies and Product Overview
4.1 Abbott Vascular Inc Company Overview
4.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
4.2 Children's Hospital Boston Company Overview
4.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
4.3 Colibri Heart Valve LLC Company Overview
4.3.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
4.4 CorMatrix Cardiovascular Inc Company Overview
4.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
4.5 CroiValve Ltd Company Overview
4.5.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.6 CryoLife Inc Company Overview
4.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
4.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview
4.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.8 Daidalos Solutions BV Company Overview
4.8.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
4.9 Edwards Lifesciences Corp Company Overview
4.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
4.10 Hancock Jaffe Laboratories Inc Company Overview
4.10.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
4.11 LivaNova PLC Company Overview
4.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
4.12 Medtronic plc Company Overview
4.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
4.13 Revivicor Inc Company Overview
4.13.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview
4.14 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
4.14.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
4.15 Stellenbosch University Company Overview
4.15.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview
4.16 Tissue Regenix Ltd Company Overview
4.16.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
4.17 University of California Irvine Company Overview
4.17.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
4.18 University of Cambridge Company Overview
4.18.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
4.19 University of Minnesota Company Overview
4.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
4.20 University of Zurich Company Overview
4.20.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview
4.21 Valcare Medical Company Overview
4.21.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview
4.22 ValveXchange, Inc. (Inactive) Company Overview
4.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
4.23 VueKlar Cardiovascular Ltd (Inactive) Company Overview
4.23.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5 Tissue Heart Valves- Recent Developments
5.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
5.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
5.3 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit
5.4 Oct 30, 2019: LivaNova reports third quarter 2019 results
5.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results

6 Appendix
6.1 Methodology
6.2 About the Author
6.3 Contact Us
6.4 Disclaimer

List of Tables
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 2: Tissue Heart Valves - Pipeline Products by Segment
Table 3: Tissue Heart Valves - Pipeline Products by Territory
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Tissue Heart Valves - Ongoing Clinical Trials
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
Table 15: Tendyne Bioprosthetic Mitral Valve Implantation System - Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects with Mitral Annular Calcification
Table 16: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Heart Valve Leaflet - Product Status
Table 18: Heart Valve Leaflet - Product Description
Table 19: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Pulmonary Valve - Product Status
Table 21: Pulmonary Valve - Product Description
Table 22: Sutureless Surgical Aortic Valve - Product Status
Table 23: Sutureless Surgical Aortic Valve - Product Description
Table 24: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: CorMatrix Cor TRICUSPID ECM Valve Device - Product Status
Table 26: CorMatrix Cor TRICUSPID ECM Valve Device - Product Description
Table 27: CorMatrix ECM - Heart Valve Repair - Product Status
Table 28: CorMatrix ECM - Heart Valve Repair - Product Description
Table 29: CorMatrix ECM - Heart Valve Replacement - Product Status
Table 30: CorMatrix ECM - Heart Valve Replacement - Product Description
Table 31: Regenerating Tubular Mitral Valve - Product Status
Table 32: Regenerating Tubular Mitral Valve - Product Description
Table 33: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
Table 34: CorMatrix Cor TRICUSPID ECM Valve Device - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
Table 35: CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Tricuspid Valve Replacement Device - Product Status
Table 37: Tricuspid Valve Replacement Device - Product Description
Table 38: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: CryoValve SGAV - Product Status
Table 40: CryoValve SGAV - Product Description
Table 41: Synergraft Xenograft Heart Valve - Product Status
Table 42: Synergraft Xenograft Heart Valve - Product Description
Table 43: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Cytograft Valve - Product Status
Table 45: Cytograft Valve - Product Description
Table 46: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Sutureless Aortic Valve Prosthesis - Product Status
Table 48: Sutureless Aortic Valve Prosthesis - Product Description
Table 49: Sutureless Mitral Valve Prostheses - Product Status
Table 50: Sutureless Mitral Valve Prostheses - Product Description
Table 51: Sutureless Tricuspid Valve Prostheses - Product Status
Table 52: Sutureless Tricuspid Valve Prostheses - Product Description
Table 53: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 54: GLX Aortic Conduit - Product Status
Table 55: GLX Aortic Conduit - Product Description
Table 56: INTUITY Valve System - Product Status
Table 57: INTUITY Valve System - Product Description
Table 58: Konect AVC - Product Status
Table 59: Konect AVC - Product Description
Table 60: Magna EASE Surgical Valve With GLX - Product Status
Table 61: Magna EASE Surgical Valve With GLX - Product Description
Table 62: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 63: INTUITY Valve System - Impact of SAVR and TAVR on Patient's Activity and Mobility CAPABILITY Study
Table 64: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
Table 65: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
Table 66: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
Table 67: Magna EASE Surgical Valve With GLX - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE

List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Figure 2: Tissue Heart Valves - Pipeline Products by Segment
Figure 3: Tissue Heart Valves - Pipeline Products by Territory
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 3
  • Abbott Vascular Inc
  • Children's Hospital Boston
  • Colibri Heart Valve LLC
  • CorMatrix Cardiovascular Inc
  • CroiValve Ltd
  • CryoLife Inc
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • Hancock Jaffe Laboratories Inc
  • LivaNova PLC
  • Medtronic plc
  • Revivicor Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tissue Regenix Ltd
  • University of California Irvine
  • University of Cambridge
  • University of Minnesota
  • University of Zurich
  • Valcare Medical
Note: Product cover images may vary from those shown
Adroll
adroll